Lexology June 27, 2024
Click here to listen to the audio
On this episode of Ropes & Gray’s podcast series, Non-binding Guidance, counsel Steve Sencer moderates a discussion on how FDA regulatory issues may impact academic medical centers (AMCs), health systems, and universities/research institutions. Joined by partner David Peloquin, and counsel Sarah Blankstein and Beth Weinman, the episode explores the complexities of FDA regulation, the potential risks, and the best practices to mitigate them. The discussion also highlights the challenges and implications of using digital tools in research studies.
Transcript:
Steve Sencer: Welcome to Non-binding Guidance, a podcast series from Ropes & Gray focused on current trends in FDA regulations and enforcement. My name is Steve Sencer, and I’m counsel in Ropes & Gray’s...
Today's Sponsors
Today's Sponsor